Find a Commonwealth Resource
Eribulin mesylate
HealthData.Gov
Updated May 26, 2026
About this dataset
Eribulin Mesylate is a generic prescription drug used intravenously to treat certain cancers. It's a microtubule inhibitor that comes as a solution in single-dose vials (0.5 mg/mL strength). Manufactured by Hikma Pharmaceuticals USA Inc., it's approved under ANDA 218281. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Eribulin mesylate
Access the FDA dataset for Eribulin mesylate — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025